Literature DB >> 10024592

Responses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis.

M S Jacewicz1, D W Acheson, D G Binion, G A West, L L Lincicome, C Fiocchi, G T Keusch.   

Abstract

Endothelial damage is characteristic of infection with Shiga toxin (Stx)-producing Escherichia coli (STEC). Because Stx-mediated endothelial cell damage at the site of infection may lead to the characteristic hemorrhagic colitis of STEC infection, we compared the effects of Stx1 and Stx2 on primary and transformed human intestinal microvascular endothelial cells (HIMEC) to those on macrovascular endothelial cells from human saphenous vein (HSVEC). Adhesion molecule, interleukin-8 (IL-8), and Stx receptor expression, the effects of cytokine activation and Stx toxins on these responses, and Stx1 and Stx2 binding kinetics and bioactivity were measured. Adhesion molecule and IL-8 expression increased in activated HIMEC, but these responses were blunted in the presence of toxin, especially in the presence of Stx1. In contrast to HSVEC, unstimulated HIMEC constitutively expressed Stx receptor at high levels, bound large amounts of toxin, were highly sensitive to toxin, and were not further sensitized by cytokines. Although the binding capacities of HIMEC for Stx1 and Stx2 were comparable, the binding affinity of Stx1 to HIMEC was 50-fold greater than that of Stx2. Nonetheless, Stx2 was more toxic to HIMEC than an equivalent amount of Stx1. The decreased binding affinity and increased toxicity for HIMEC of Stx2 compared to those of Stx1 may be relevant to the preponderance of Stx2-producing STEC involved in the pathogenesis of hemorrhagic colitis and its systemic complications. The differences between primary and transformed HIMEC in these responses were negligible. We conclude that transformed HIMEC lines could represent a simple physiologically relevant model to study the role of Stx in the pathogenesis of hemorrhagic colitis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10024592      PMCID: PMC96478     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Comparison of the effects of Shiga-like toxin 1 on cytokine- and butyrate-treated human umbilical and saphenous vein endothelial cells.

Authors:  G T Keusch; D W Acheson; L Aaldering; J Erban; M S Jacewicz
Journal:  J Infect Dis       Date:  1996-05       Impact factor: 5.226

2.  Isolation and longterm culture of human intestinal microvascular endothelial cells.

Authors:  G Haraldsen; J Rugtveit; D Kvale; T Scholz; W A Muller; T Hovig; P Brandtzaeg
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

Review 3.  Southwestern Internal Medicine Conference: Shiga-like toxins in hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura.

Authors:  S L Hofmann
Journal:  Am J Med Sci       Date:  1993-12       Impact factor: 2.378

4.  Translocation of Shiga toxin across polarized intestinal cells in tissue culture.

Authors:  D W Acheson; R Moore; S De Breucker; L Lincicome; M Jacewicz; E Skutelsky; G T Keusch
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

5.  Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells.

Authors:  P A van Setten; V W van Hinsbergh; T J van der Velden; N C van de Kar; M Vermeer; J D Mahan; K J Assmann; L P van den Heuvel; L A Monnens
Journal:  Kidney Int       Date:  1997-04       Impact factor: 10.612

6.  Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells.

Authors:  C B Louise; T G Obrig
Journal:  J Infect Dis       Date:  1995-11       Impact factor: 5.226

7.  Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.

Authors:  C B Louise; T G Obrig
Journal:  Microvasc Res       Date:  1994-05       Impact factor: 3.514

8.  Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells.

Authors:  G Haraldsen; D Kvale; B Lien; I N Farstad; P Brandtzaeg
Journal:  J Immunol       Date:  1996-04-01       Impact factor: 5.422

Review 9.  Tumor necrosis factor and interleukin 1 induce expression of the glycolipid verotoxin receptor in human endothelial cells. Implications for the pathogenesis of the haemolytic uraemic syndrome.

Authors:  N C Van de Kar; L A Monnens; V W Van Hinsbergh
Journal:  Behring Inst Mitt       Date:  1993-08

10.  Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines.

Authors:  B Ramegowda; V L Tesh
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

View more
  26 in total

1.  Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells.

Authors:  B P Hurley; M Jacewicz; C M Thorpe; L L Lincicome; A J King; G T Keusch; D W Acheson
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

2.  Intestinal damage in enterohemorrhagic Escherichia coli infection.

Authors:  Zivile D Békássy; Carla Calderon Toledo; Gustav Leoj; Anncharlotte Kristoffersson; Shana R Leopold; Maria-Thereza Perez; Diana Karpman
Journal:  Pediatr Nephrol       Date:  2010-09-01       Impact factor: 3.714

Review 3.  Glycosphingolipid functions.

Authors:  Clifford A Lingwood
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

4.  Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide.

Authors:  Steven D Zumbrun; Leanne Hanson; James F Sinclair; James Freedy; Angela R Melton-Celsa; Jaime Rodriguez-Canales; Jeffrey C Hanson; Alison D O'Brien
Journal:  Infect Immun       Date:  2010-08-23       Impact factor: 3.441

Review 5.  Shiga toxins expressed by human pathogenic bacteria induce immune responses in host cells.

Authors:  Moo-Seung Lee; Myung Hee Kim; Vernon L Tesh
Journal:  J Microbiol       Date:  2013-12-19       Impact factor: 3.422

Review 6.  Toxins and the gut: role in human disease.

Authors:  A Fasano
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

7.  Rapid cytopathic effects of Clostridium perfringens beta-toxin on porcine endothelial cells.

Authors:  Corinne Gurtner; Francesca Popescu; Marianne Wyder; Esther Sutter; Friederike Zeeh; Joachim Frey; Conrad von Schubert; Horst Posthaus
Journal:  Infect Immun       Date:  2010-04-19       Impact factor: 3.441

8.  Shigatoxin-1 binding and receptor expression in human kidneys do not change with age.

Authors:  Zuhal Ergonul; Frederic Clayton; Agnes B Fogo; Donald E Kohan
Journal:  Pediatr Nephrol       Date:  2003-02-07       Impact factor: 3.714

Review 9.  Renal and neurological involvement in typical Shiga toxin-associated HUS.

Authors:  Howard Trachtman; Catherine Austin; Maria Lewinski; Rolf A K Stahl
Journal:  Nat Rev Nephrol       Date:  2012-09-18       Impact factor: 28.314

10.  Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression with differential Shiga toxin 1 cytotoxicity.

Authors:  Christian H Schweppe; Martina Bielaszewska; Gottfried Pohlentz; Alexander W Friedrich; Heino Büntemeyer; M Alexander Schmidt; Kwang S Kim; Jasna Peter-Katalinić; Helge Karch; Johannes Müthing
Journal:  Glycoconj J       Date:  2008-01-05       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.